VF
KRBP

Virtu Financial’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

Virtu Financial’s Portfolio KRBP Stock Details KRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,060
Closed -$6K – 2434
2022
Q4 		$6K Buy
+1,060
New +$8.52K ﹤0.01% 1442
2022
Q3 		– Sell
-866
Closed -$11K – 2461
2022
Q2 		$11K Buy
+866
New +$13.7K ﹤0.01% 1424
2021
Q4 		– Sell
-582
Closed -$54K – 2353
2021
Q3 		$54K Buy
+582
New +$60.2K ﹤0.01% 1265

Other funds holding KRBP

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Virtu Financial's KRBP Position: Q1 2023 in Review

Virtu Financial sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q1 2023, closing a stake of 1,060 shares — an estimated $6K sold.

Virtu Financial first reported a position in KRBP in Q3 2021 and held it in 3 quarters. The position peaked at $54K in Q3 2021. 7 funds tracked by Wall St. Rank hold KRBP as of Q1 2023.

  • Virtu Financial reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Virtu Financial sold 1,060 Kiromic BioPharma, Inc. Common Stock shares in Q1 2023, an estimated $6K.
  • Virtu Financial first reported a position in Kiromic BioPharma, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Virtu Financial's Kiromic BioPharma, Inc. Common Stock position peaked at $54K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.